News Alert

House Passes Pediatric Enrollment Bill That Would Require 340B Providers to Report Medicaid Managed Care Revenue

The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase reporting requirements for certain 340B providers.
The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eli Lilly and Amgen Announce Refunds, Amgen Issues NDC Change

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.
Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Adds Louisiana to Eligible States for Immediate 340B Enrollment Due to Hurricane Francine 

HHS declared a Public Health Emergency for Louisiana following Hurricane Francine.
Louisiana providers can enroll in the 340B program outside of the formal enrollment period amid disaster relief efforts following Hurricane [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca Tightens Contract Pharmacy Restrictions to Require Claims Data Submission

AstraZeneca headquarters
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.
Beginning Oct. 1, AstraZeneca will tighten its 340B contract pharmacy restrictions to require claims data on 340B utilization at contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

ACA Played Key Role in 340B Growth, Drug Industry Consulting Firm Finds

IQVIA headquarters
An IQVIA analysis looked at the 340B program’s growth under the Affordable Care Act.
The 340B program has outgrown patient demands and requires additional restrictions and oversight, according to a new report from a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Calls on Congress to Defend 340B Access to Specialty, Community Pharmacies Amid Drugmaker Resistance

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
Specialty and community pharmacies play an essential role in the 340B program and must be protected against interference by drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Experts Forecast Impact of November Elections on 340B Program, Drug Pricing and the Larger Economy

340B Report hosted a subscriber-only webinar on the 2024 elections on Sept. 5.
November will bring an epic battle for both the U.S. presidency and control in Congress, both of which could have [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Relents on Arkansas Contract Pharmacy Law; AbbVie Exempts MO, MS Covered Entities

Johnson & Johnson building-mounted sign
Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.
Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kedrion Posts 340B Refund Notice; Mylan Issue NDC Changes

Kedrion was one of two drugmakers to issue recent notices to covered entities on a federal government agency website.
Drugmaker Kedrion Biopharma has posted a refund notice to 340B providers, and Mylan notified covered entities of National Drug Code [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups ask Supreme Court to Reverse Ruling that Impacts 340B Eligibility

Hospital groups are urging the Supreme Court to correct what they called HHS' misinterpretation of DSH percentage calculations.
Six national hospital associations recently urged the Supreme Court to correct what they called the Department of Health and Human [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live